Selected UIC References:

Al-Alem, Umaima, Abeer M. Mahmoud, Ken Batai, et al. “Genetic Variation and Immunohistochemical Localization of the Glucocorticoid Receptor in Breast Cancer Cases from the Breast Cancer Care in Chicago Cohort.” Cancers 13, no. 10 (2021): 2261. https://doi.org/10.3390/cancers13102261.

Ansong, Emmanuel, Qi Ying, Dede N. Ekoue, et al. “Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer.” PloS One 10, no. 5 (2015): e0127295. https://doi.org/10.1371/journal.pone.0127295.

Bendre, Shruti V., Yu Wang, Basel Hajyousif, et al. “Cholesterol Efflux Protein, ABCA1, Supports Anticancer Functions of Myeloid Immune Cells.” Science Advances 12, no. 1 (2026): eadx5490. https://doi.org/10.1126/sciadv.adx5490.

Bera, Soumen, Li Liu, Weiwei Ma, et al. “Contributions of Selenoproteins to Breast Cancer Etiology and Racial Disparity.” Cancer Causes & Control: CCC 37, no. 2 (2026): 35. https://doi.org/10.1007/s10552-025-02123-y.

Ekoue, Dede N., Emmanuel Ansong, Li Liu, et al. “Correlations of SELENOF and SELENOP Genotypes with Serum Selenium Levels and Prostate Cancer.” The Prostate 78, no. 4 (2018): 279–88. https://doi.org/10.1002/pros.23471.

Gaba, Ron C., Ramzy C. Khabbaz, Ruth N. Muchiri, et al. “Conventional versus Drug-Eluting Embolic Transarterial Chemoembolization with Doxorubicin: Comparative Drug Delivery, Pharmacokinetics, and Treatment Response in a Rabbit VX2 Tumor Model.” Drug Delivery and Translational Research 12, no. 5 (2022): 1105–17. https://doi.org/10.1007/s13346-021-00985-8.

Gann, Peter H., Ryan J. Deaton, Nathan McMahon, et al. “An Anti-IL-13 Antibody Reverses Epithelial-Mesenchymal Transition Biomarkers in Eosinophilic Esophagitis: Phase 2 Trial Results.” The Journal of Allergy and Clinical Immunology 146, no. 2 (2020): 367-376.e3. https://doi.org/10.1016/j.jaci.2020.03.045.

Gao, Xin, Chenguang Wang, Suhaib Abdelrahman, et al. “Notch Signaling Promotes Mature T-Cell Lymphomagenesis.” Cancer Research 82, no. 20 (2022): 3763–73. https://doi.org/10.1158/0008-5472.CAN-22-1215.

Garcia, Jason, Kirsten D. Krieger, Candice Loitz, et al. “Regulation of Prostate Androgens by Megalin and 25-Hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men.” Cancer Research Communications 3, no. 3 (2023): 371–82. https://doi.org/10.1158/2767-9764.CRC-22-0362.

Kim, Ki-Hyun, Seung-Jae Kim, Jacob D. Eccles, Christian Ascoli, and Gye Young Park. “Tumor Immunogenicity Regulates Host Immune Responses, and Conventional Dendritic Cell Type 2 Uptakes the Majority of Tumor Antigens in an Orthotopic Lung Cancer Model.” Cancer Immunology, Immunotherapy: CII 73, no. 12 (2024): 237. https://doi.org/10.1007/s00262-024-03828-w.

Kurian, Nikhil Cherian, Peter H. Gann, Neeraj Kumar, Stephanie M. McGregor, Ruchika Verma, and Amit Sethi. “Deep Learning Predicts Subtype Heterogeneity and Outcomes in Luminal A Breast Cancer Using Routinely Stained Whole-Slide Images.” Cancer Research Communications 5, no. 1 (2025): 157–66. https://doi.org/10.1158/2767-9764.CRC-24-0397.

Mahmoud, Abeer M., Eileen Brister, Odile David, et al. “Machine Learning for Digital Scoring of PRMT6 in Immunohistochemical Labeled Lung Cancer.” Cancers 15, no. 18 (2023): 4582. https://doi.org/10.3390/cancers15184582.

Mahmoud, Abeer M., Virgilia Macias, Umaima Al-Alem, et al. “BRCA1 Protein Expression and Subcellular Localization in Primary Breast Cancer: Automated Digital Microscopy Analysis of Tissue Microarrays.” PloS One 12, no. 9 (2017): e0184385. https://doi.org/10.1371/journal.pone.0184385.

Moon, Hyung-Geun, Jacob D. Eccles, Seung-Jae Kim, et al. “Complement C1q Essential for Aeroallergen Sensitization via CSF1R+ Conventional Dendritic Cells Type 2.” The Journal of Allergy and Clinical Immunology 152, no. 5 (2023): 1141-1152.e2. https://doi.org/10.1016/j.jaci.2023.07.016.

Moon, Hyung-Geun, Seung-Jae Kim, Jong Jin Jeong, et al. “Airway Epithelial Cell-Derived Colony Stimulating Factor-1 Promotes Allergen Sensitization.” Immunity 49, no. 2 (2018): 275-287.e5. https://doi.org/10.1016/j.immuni.2018.06.009.

Moon, Hyung-Geun, Seung-Jae Kim, Myoung Kyu Lee, et al. “Colony-Stimulating Factor 1 and Its Receptor Are New Potential Therapeutic Targets for Allergic Asthma.” Allergy 75, no. 2 (2020): 357–69. https://doi.org/10.1111/all.14011.

Moreno-Vinasco, Liliana, Hector Quijada, Saad Sammani, et al. “Nicotinamide Phosphoribosyltransferase Inhibitor Is a Novel Therapeutic Candidate in Murine Models of Inflammatory Lung Injury.” American Journal of Respiratory Cell and Molecular Biology 51, no. 2 (2014): 223–28. https://doi.org/10.1165/rcmb.2012-0519OC.

Shaheed, Avneet, Shriya Mehta, Maria Sverdlov, et al. “SELENOF and Its Translational Inhibitor EIF4A3 Are Differentially Expressed in Colon Cancer.” Archives of Biochemistry and Biophysics 780 (June 2026): 110796. https://doi.org/10.1016/j.abb.2026.110796.

 

References Illustrating Methods:

Alcindor, Thierry, James Tankel, Pierre-Olivier Fiset, et al. “Phase 2 Trial of Perioperative Chemo-Immunotherapy for Gastro-Esophageal Adenocarcinoma: The Role of M2 Macrophage Landscape in Predicting Response.” Cell Reports Medicine 6, no. 4 (2025). https://doi.org/10.1016/j.xcrm.2025.102045.

Aronson, S. L., B. Thijssen, M. Lopez-Yurda, et al. “Neo-Adjuvant Pembrolizumab in Stage IV High-Grade Serous Ovarian Cancer: The Phase II Neo-Pembro Trial.” Nature Communications 16, no. 1 (2025): 3520. https://doi.org/10.1038/s41467-025-58440-y.

Butler, Morgane L. M. D., Nida Pervaiz, Kerry Breen, et al. “Repeated Head Trauma Causes Neuron Loss and Inflammation in Young Athletes.” Nature 647, no. 8088 (2025): 228–37. https://doi.org/10.1038/s41586-025-09534-6.

Estephan, Hala, Arun Tailor, Robert Parker, et al. “Hypoxia Promotes Tumor Immune Evasion by Suppressing MHC-I Expression and Antigen Presentation.” The EMBO Journal 44, no. 3 (2025): 903–22. https://doi.org/10.1038/s44318-024-00319-7.

Frei, Anja L., Anthony McGuigan, Ritik R. A. K. Sinha, et al. “Multiplex Analysis of Intratumoural Immune Infiltrate and Prognosis in Patients with Stage II–III Colorectal Cancer from the SCOT and QUASAR 2 Trials: A Retrospective Analysis.” The Lancet Oncology 25, no. 2 (2024): 198–211. https://doi.org/10.1016/S1470-2045(23)00560-0.

Ma, Yuanzhen, Xiaodong Su, Tingting Zeng, et al. “CCL5hi Macrophages Interact with CD8+ T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma.” Advanced Science 12, no. 45 (2025): e09187. https://doi.org/10.1002/advs.202409187.

Ressler, Julia Maria, Maud Plaschka, Rita Silmbrod, et al. “Efficacy and Tolerability of Neoadjuvant Therapy with Talimogene Laherparepvec in Cutaneous Basal Cell Carcinoma: A Phase II Trial (NeoBCC Trial).” Nature Cancer 6, no. 1 (2025): 51–66. https://doi.org/10.1038/s43018-024-00879-x.

Van Acker, Nathalie, François-Xavier Frenois, Pauline Gravelle, et al. “Spatial Mapping of Innate Lymphoid Cells in Human Lymphoid Tissues and Lymphoma at Single-Cell Resolution.” Nature Communications 16, no. 1 (2025): 4545. https://doi.org/10.1038/s41467-025-59811-1.

Virassamy, Balaji, Franco Caramia, Peter Savas, et al. “Parity and Lactation Induce T-Cell-Mediated Breast Cancer Protection.” Nature 649, no. 8096 (2026): 449–59. https://doi.org/10.1038/s41586-025-09713-5.